General Announcement::S&P Global Ratings

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
24-Nov-2020 22:30:34
Status
New
Announcement Sub Title
S&P Global Ratings
Announcement Reference
SG201124OTHRBZKE
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
24/11/2020 00:00:00
Description (Please provide a detailed description of the event in the box below)
Kindly find enclosed rating research update issued by S&P Global Ratings for your reference.

Attachments

SGX_SP_CREDIT_RATING.pdf
Total size =299K